Pfizer's ELREXFIO™ receives U.S. FDA accelerated approval for relapsed or refractory multiple myeloma
- Details
- Category: Pfizer

Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years
- Details
- Category: Bayer

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries
- Details
- Category: Pfizer

New research published in Science highlights potential of a naturally occurring bacterium to help eradicate malaria
- Details
- Category: GlaxoSmithKline

AI drives new era of target identification and drug design
- Details
- Category: Business

Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
- Details
- Category: AstraZeneca

Pfizer announces executive leadership to advance oncology research and development strategy
- Details
- Category: Pfizer

Effective today, Chris Boshoff, M.D., PhD, will join Pfizer's Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to
More Pharma News ...
- AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets
- Pfizer announces New England Journal of Medicine publication on Group B Streptococcus (GBS) maternal vaccine candidate
- Novartis builds on neuroscience pipeline and xRNA platform capabilities with acquisition of DTx Pharma
- Flagship Pioneering and Pfizer partner to accelerate development of innovative medicines targeting unmet needs
- AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
- AbbVie secures positive CHMP opinion for atogepant for the preventive treatment of adults with migraine
- Bayer extends partnership with Peking University to foster pharmaceutical innovation in China